Asarfi Hospital Ltd
Asarfi Hospital Ltd (ASARFI) last reported results for the quarter ended Jun 2026, with sales of ₹47.53 crore and net profit of ₹4.27 crore. The stock last traded at ₹189, a market capitalisation of ₹373 crore, on a P/E of 20.9. Over the past 52 weeks the stock has ranged between ₹125 and ₹257. Figures are as of 6 Oct 2026 and are not real time.
Asarfi Hospital Ltd share price and key metrics
- Current price
- ₹189
- Market cap
- ₹373 cr
- Stock P/E
- 20.9
- Book value
- ₹51.8
- ROE
- 18.6%
- ROCE
- 18.6%
- Dividend yield
- 0.00%
- 52w high / low
- 257/125
Metrics as of 6 Oct 2026. Not real time.
Track Asarfi Hospital Ltd
Cruxal reads every Asarfi Hospital Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Asarfi Hospital Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- 37%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- 46%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 19%
- 1 Year
- 39%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 13%
- Last Year
- 19%
Asarfi Hospital Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹47.53 cr, up 33.2% from ₹35.68 cr a year earlier. Net profit was ₹4.27 cr, up 36.9% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 30.86 | 32.89 | 35.1 | 35.68 | 44.89 | 46.1 | 45.24 | 47.53 |
| Expenses | 24.1 | 25.93 | 28.81 | 28.69 | 36.02 | 36 | 37.51 | 38.08 |
| Operating profit | 6.76 | 6.96 | 6.29 | 6.99 | 8.87 | 10.1 | 7.73 | 9.45 |
| OPM % | 21.91% | 21.16% | 17.92% | 19.59% | 19.76% | 21.91% | 17.09% | 19.88% |
| Other income | 1.13 | 0.89 | 3.61 | 1.42 | 0.76 | 1.48 | 0.64 | 0.57 |
| Interest | 0.76 | 1.18 | 1.35 | 1.22 | 1.07 | 1.25 | 0.71 | 1.17 |
| Depreciation | 3.19 | 3.05 | 3.25 | 2.99 | 2.91 | 2.88 | 2.76 | 3.15 |
| Profit before tax | 3.94 | 3.62 | 5.3 | 4.2 | 5.65 | 7.45 | 4.9 | 5.7 |
| Tax % | 27.41% | 25.69% | 32.26% | 25.71% | 25.66% | 27.25% | 20.20% | 25.26% |
| Net profit | 2.85 | 2.68 | 3.59 | 3.12 | 4.2 | 5.42 | 3.92 | 4.27 |
| EPS (₹) | 1.45 | 1.36 | 1.82 | 1.59 | 2.13 | 2.75 | 1.99 | 2.17 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Asarfi Hospital Ltd annual results
| ₹ crore | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|
| Sales | 81 | 118 | 159 | 184 |
| Operating profit | 16 | 25 | 35 | 36 |
| OPM % | 20% | 21% | 22% | 20% |
| Net profit | 4 | 11 | 17 | 18 |
| EPS (₹) | 2.11 | 5.38 | 8.47 | 9.04 |
TTM is the trailing twelve months to the most recent quarter.
Asarfi Hospital Ltd balance sheet
| ₹ crore | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Equity capital | 20 | 20 | 20 |
| Reserves | 51 | 61 | 78 |
| Borrowings | 32 | 49 | 58 |
| Other liabilities | 52 | 34 | 38 |
| Total liabilities | 154 | 164 | 193 |
| Fixed assets | 94 | 102 | 108 |
| CWIP | 0 | 2 | 2 |
| Investments | 0 | 0 | 0 |
| Other assets | 60 | 60 | 83 |
| Total assets | 154 | 164 | 193 |
As reported by the company. Total assets equal total liabilities by construction.
Asarfi Hospital Ltd cash flow
| ₹ crore | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Cash from operations | 26 | -4 | 18 |
| Cash from investing | -63 | -7 | -18 |
| Cash from financing | 36 | 13 | 5 |
| Net cash flow | -1 | 1 | 5 |
| Free cash flow | -20 | -15 | 0 |
| CFO / operating profit | 163% | -5% | 68% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Asarfi Hospital Ltd operating ratios
| Per year | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| ROCE % | — | 16% | 19% |
| Debtor days | 109 | 123 | 124 |
| Inventory days | 32 | 30 | 30 |
| Days payable | 447 | 167 | 156 |
| Cash conversion cycle | -305 | -13 | -1 |
| Working capital days | 3 | 4 | 21 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Asarfi Hospital Ltd shareholding pattern
Promoters held 61.17% at Jun 2026, broadly unchanged since Jun 2025. FIIs 0.00% and DIIs 2.97%.
| % held | Mar 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 61.17% | 61.17% | 61.17% | 61.17% | 61.17% | 61.17% | 61.17% | 61.17% |
| FIIs | 0.00% | 0.00% | 0.00% | 0.10% | 0.05% | 0.00% | 0.00% | 0.00% |
| DIIs | 2.33% | 1.95% | 2.92% | 3.19% | 2.18% | 1.98% | 2.40% | 2.97% |
| Public | 36.50% | 36.89% | 35.92% | 35.55% | 36.59% | 36.86% | 36.44% | 35.87% |
| No. of shareholders | 1,261 | 1,284 | 1,262 | 1,176 | 1,167 | 1,225 | 1,316 | 1,399 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Asarfi Hospital Ltd corporate filings
- CRISIL Upgrades Credit Rating of Asarfi Hospital Limited’s Bank Facilities to 'BBB/Stable' with Enhanced Loan Limit to ₹60 CroreCompany Updatehigh impact
Cruxal's analysis: The announcement reports a significant upgrade in Asarfi Hospital Limited’s credit rating…
Read the full analysis - We hereby inform you that the Trading Window for dealing in the securities of the company shall remain closed for all designated persons and their Immediate Relatives with effected from ....Insider Trading / SASTlow impact
- Asarfi Hospital Limited shareholders approve migration from BSE SME to Main BoardAGM/EGMhigh impact
Cruxal's analysis: Asarfi Hospital Limited has successfully secured shareholder approval at its 21st Annual…
Read the full analysis - Asarfi Hospital Limited Receives Shareholder Approval for Migration to BSE Main Board and NSE ListingAGM/EGMhigh impact
Cruxal's analysis: Asarfi Hospital Limited has successfully concluded its 21st Annual General Meeting, where…
Read the full analysis - Asarfi Hospital Limited submits Annual Report for FY 2025-26 and AGM noticeOtherslow impact
Cruxal's analysis: Asarfi Hospital Limited has filed its Annual Report for the financial year 2025-26, which…
Read the full analysis - Asarfi Hospital Limited Announces Appointment of Cost Auditor for FY 2026-27Company Updatelow impact
Cruxal's analysis: Asarfi Hospital Limited has formally appointed M/s Ashutosh Kumar Sinha & Co as the Cost…
Read the full analysis - Asarfi Hospital Limited Announces Board Approval for Migration from BSE SME to Main Board and Proposed NSE ListingBoard Meetinghigh impact
Cruxal's analysis: Asarfi Hospital Limited has formally approved the migration of its equity shares from the…
Read the full analysis - Asarfi Hospital Limited Initiates Board Deliberations for Migration from BSE SME to Main Board and NSE ListingBoard Meetinghigh impact
Cruxal's analysis: Asarfi Hospital Limited has announced that its upcoming Board Meeting on 25 August 2026…
Read the full analysis - Asarfi Hospital Limited Reports Strong Q1 FY27 Financials with 33% YoY Revenue Growth and Margin ExpansionCompany Updatehigh impact
Cruxal's analysis: Asarfi Hospital Limited has reported robust financial results for the quarter ended June…
Read the full analysis - Asarfi Hospital Ltd submits routine press release under Regulation 30Company Updatelow impact
Cruxal's analysis: Asarfi Hospital Ltd has filed a press release/media release in compliance with Regulation…
Read the full analysis - Asarfi Hospital Limited Reports Strong Q1 FY27 Financials with 33.2% YoY Revenue Growth and 36.7% YoY PAT GrowthCompany Updatehigh impact
Cruxal's analysis: Asarfi Hospital Limited delivered robust Q1 FY27 results, with consolidated revenue from…
Read the full analysis - Asarfi Hospital Limited Reports Strong Q1 FY27 Financial Results with 36.8% YoY Revenue GrowthBoard Meetinghigh impact
Cruxal's analysis: Asarfi Hospital Limited has reported robust financial results for the quarter ended 30…
Read the full analysis - Asarfi Hospital Limited schedules Board Meeting for 7th August 2026 to approve Q1 FY27 financial resultsBoard Meetinglow impact
Cruxal's analysis: Asarfi Hospital Limited has issued a formal notice for its 3rd Board Meeting of the…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.